Financial Analysis: Moolec Science (NASDAQ:MLEC) versus Thunder Bridge Capital Partners IV (NASDAQ:THCP)

Moolec Science (NASDAQ:MLEC) and Thunder Bridge Capital Partners IV (NASDAQ:THCP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

Insider and Institutional Ownership

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 33.2% of Thunder Bridge Capital Partners IV shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Comparatively, 65.1% of Thunder Bridge Capital Partners IV shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Moolec Science and Thunder Bridge Capital Partners IV, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
Thunder Bridge Capital Partners IV	0	0	0	0	N/A

Moolec Science presently has a consensus price target of $6.00, suggesting a potential upside of 552.17%. Given Moolec Science’s higher possible upside, analysts clearly believe Moolec Science is more favorable than Thunder Bridge Capital Partners IV.

Profitability

This table compares Moolec Science and Thunder Bridge Capital Partners IV’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-93.88%	-33.37%
Thunder Bridge Capital Partners IV	N/A	-15.04%	-0.48%

Earnings & Valuation

This table compares Moolec Science and Thunder Bridge Capital Partners IV”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$5.63 million	6.14	-$7.31 million	($0.20)	-4.60
Thunder Bridge Capital Partners IV	N/A	N/A	$4.09 million	N/A	N/A

Thunder Bridge Capital Partners IV has lower revenue, but higher earnings than Moolec Science.

Summary

Thunder Bridge Capital Partners IV beats Moolec Science on 6 of the 9 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About Thunder Bridge Capital Partners IV

Thunder Bridge Capital Partners IV Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Great Falls, Virginia.